Cargando…

Expression Analysis of NF-κB-Related lncRNAs in Parkinson’s Disease

Parkinson’s disease (PD) has been shown to affect approximately 1% of the persons aged more than 65 years. This multifactorial disorder has been associated with abnormal function of NF-κB signals. In this research, we have evaluated expressions of NF-κB-related long non-coding RNAs in the circulatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghafouri-Fard, Soudeh, Gholipour, Mahdi, Abak, Atefe, Mazdeh, Mehrdokht, Taheri, Mohammad, Sayad, Arezou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548831/
https://www.ncbi.nlm.nih.gov/pubmed/34721431
http://dx.doi.org/10.3389/fimmu.2021.755246
_version_ 1784590665833775104
author Ghafouri-Fard, Soudeh
Gholipour, Mahdi
Abak, Atefe
Mazdeh, Mehrdokht
Taheri, Mohammad
Sayad, Arezou
author_facet Ghafouri-Fard, Soudeh
Gholipour, Mahdi
Abak, Atefe
Mazdeh, Mehrdokht
Taheri, Mohammad
Sayad, Arezou
author_sort Ghafouri-Fard, Soudeh
collection PubMed
description Parkinson’s disease (PD) has been shown to affect approximately 1% of the persons aged more than 65 years. This multifactorial disorder has been associated with abnormal function of NF-κB signals. In this research, we have evaluated expressions of NF-κB-related long non-coding RNAs in the circulation of PD patients compared with healthy controls. Expression of PACER was lower in total PD patients compared with healthy persons (Ratio of mean expressions (RME)=0.32, P value<0.001). This pattern was also evident among males (RME=0.25, P value<0.001). Expression of DILC was higher in total PD patients (RME=4.07, P value<0.001), and in both sex-based subgroups (RME=3.77, P value=0.01 and RME=4.25, P value<0.001, for females and males, respectively). Similarly, CEBPA was significantly over-expressed in total PD patients (RME=14.76, P value<0.001), and in both sex-based subgroups (RME=12.42, P value<0.001 and RME=15.80, P value<0.001, for females and males, respectively). ATG5 had a similar expression pattern (RME=2.6, P value=1E-08, RME=1.73, P value=0.03 and RME=3.09, P value=1E-07, for total cases, females and males, respectively). H19 was up-regulated in total cases and male cases compared with corresponding controls (RME=2.19, P value<0.001, RME=2.68, P value=0.01, respectively). Finally, HNFA1-AS was down-regulated in all comparisons (RME=0.10, P value=2E-06, RME=0.08, P value<0.001 and RME=0.12, P value<0.001, for total cases, females and males, respectively). Among PD patients, expressions of NKILA and ADINR were robustly correlated with each other (r=0.75, P value=2.40E-10). In addition, expression levels of DICER1-AS were significantly correlated with those of ADINR, PACER and H19 in these patients (r=0.73, P value=1.76E-9; r=0.72, P value=5.15E-09 and r=0.72, P value=3.09E-09, respectively). Correlation analyses among healthy controls revealed robust correlations between CHAST and CEBPA (r=0.84, P value=3.09E-09), NKILA and ADINR (r=0.80, P value=4.24E-12) as well as between DILC and CHAST (r=0.76, P value=1.70E-10). CEBPA had the best parameters among all assessed genes (AUC=0.96, Sensitivity=0.90 and specificity=0.97). DILC and ATG5 were the most appropriate markers after CEBPA with AUC values of 0.82 and 0.80, respectively. Most notably, combination of all genes improved AUC, sensitivity and specificity parameters to 1, 0.97 and 0.99, respectively. Cumulatively, the current study provides evidence for participation of NF-κB-related lncRNAs in the pathoetiology of PD.
format Online
Article
Text
id pubmed-8548831
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-85488312021-10-28 Expression Analysis of NF-κB-Related lncRNAs in Parkinson’s Disease Ghafouri-Fard, Soudeh Gholipour, Mahdi Abak, Atefe Mazdeh, Mehrdokht Taheri, Mohammad Sayad, Arezou Front Immunol Immunology Parkinson’s disease (PD) has been shown to affect approximately 1% of the persons aged more than 65 years. This multifactorial disorder has been associated with abnormal function of NF-κB signals. In this research, we have evaluated expressions of NF-κB-related long non-coding RNAs in the circulation of PD patients compared with healthy controls. Expression of PACER was lower in total PD patients compared with healthy persons (Ratio of mean expressions (RME)=0.32, P value<0.001). This pattern was also evident among males (RME=0.25, P value<0.001). Expression of DILC was higher in total PD patients (RME=4.07, P value<0.001), and in both sex-based subgroups (RME=3.77, P value=0.01 and RME=4.25, P value<0.001, for females and males, respectively). Similarly, CEBPA was significantly over-expressed in total PD patients (RME=14.76, P value<0.001), and in both sex-based subgroups (RME=12.42, P value<0.001 and RME=15.80, P value<0.001, for females and males, respectively). ATG5 had a similar expression pattern (RME=2.6, P value=1E-08, RME=1.73, P value=0.03 and RME=3.09, P value=1E-07, for total cases, females and males, respectively). H19 was up-regulated in total cases and male cases compared with corresponding controls (RME=2.19, P value<0.001, RME=2.68, P value=0.01, respectively). Finally, HNFA1-AS was down-regulated in all comparisons (RME=0.10, P value=2E-06, RME=0.08, P value<0.001 and RME=0.12, P value<0.001, for total cases, females and males, respectively). Among PD patients, expressions of NKILA and ADINR were robustly correlated with each other (r=0.75, P value=2.40E-10). In addition, expression levels of DICER1-AS were significantly correlated with those of ADINR, PACER and H19 in these patients (r=0.73, P value=1.76E-9; r=0.72, P value=5.15E-09 and r=0.72, P value=3.09E-09, respectively). Correlation analyses among healthy controls revealed robust correlations between CHAST and CEBPA (r=0.84, P value=3.09E-09), NKILA and ADINR (r=0.80, P value=4.24E-12) as well as between DILC and CHAST (r=0.76, P value=1.70E-10). CEBPA had the best parameters among all assessed genes (AUC=0.96, Sensitivity=0.90 and specificity=0.97). DILC and ATG5 were the most appropriate markers after CEBPA with AUC values of 0.82 and 0.80, respectively. Most notably, combination of all genes improved AUC, sensitivity and specificity parameters to 1, 0.97 and 0.99, respectively. Cumulatively, the current study provides evidence for participation of NF-κB-related lncRNAs in the pathoetiology of PD. Frontiers Media S.A. 2021-10-13 /pmc/articles/PMC8548831/ /pubmed/34721431 http://dx.doi.org/10.3389/fimmu.2021.755246 Text en Copyright © 2021 Ghafouri-Fard, Gholipour, Abak, Mazdeh, Taheri and Sayad https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Ghafouri-Fard, Soudeh
Gholipour, Mahdi
Abak, Atefe
Mazdeh, Mehrdokht
Taheri, Mohammad
Sayad, Arezou
Expression Analysis of NF-κB-Related lncRNAs in Parkinson’s Disease
title Expression Analysis of NF-κB-Related lncRNAs in Parkinson’s Disease
title_full Expression Analysis of NF-κB-Related lncRNAs in Parkinson’s Disease
title_fullStr Expression Analysis of NF-κB-Related lncRNAs in Parkinson’s Disease
title_full_unstemmed Expression Analysis of NF-κB-Related lncRNAs in Parkinson’s Disease
title_short Expression Analysis of NF-κB-Related lncRNAs in Parkinson’s Disease
title_sort expression analysis of nf-κb-related lncrnas in parkinson’s disease
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548831/
https://www.ncbi.nlm.nih.gov/pubmed/34721431
http://dx.doi.org/10.3389/fimmu.2021.755246
work_keys_str_mv AT ghafourifardsoudeh expressionanalysisofnfkbrelatedlncrnasinparkinsonsdisease
AT gholipourmahdi expressionanalysisofnfkbrelatedlncrnasinparkinsonsdisease
AT abakatefe expressionanalysisofnfkbrelatedlncrnasinparkinsonsdisease
AT mazdehmehrdokht expressionanalysisofnfkbrelatedlncrnasinparkinsonsdisease
AT taherimohammad expressionanalysisofnfkbrelatedlncrnasinparkinsonsdisease
AT sayadarezou expressionanalysisofnfkbrelatedlncrnasinparkinsonsdisease